TY - JOUR
T1 - Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women
AU - United States-Latin American Cancer Research Network (US-LACRN)
AU - de Almeida, Liz Maria
AU - Cortés, Sandra
AU - Vilensky, Marta
AU - Valenzuela, Olivia
AU - Cortes-Sanabria, Laura
AU - de Souza, Mirian
AU - Barbeito, Rafael Alonso
AU - Abdelhay, Eliana
AU - Artagaveytia, Nora
AU - Daneri-Navarro, Adrian
AU - Llera, Andrea S.
AU - Müller, Bettina
AU - Podhajcer, Osvaldo L.
AU - Velazquez, Carlos
AU - Alcoba, Elsa
AU - Alonso, Isabel
AU - Bravo, Alicia I.
AU - Camejo, Natalia
AU - Carraro, Dirce Maria
AU - Castro, Mónica
AU - Cataldi, Sandra
AU - Cayota, Alfonso
AU - Cerda, Mauricio
AU - Colombo, Alicia
AU - Crocamo, Susanne
AU - Del Toro-Arreola, Alicia
AU - Delgadillo-Cristerna, Raul
AU - Delgado, Lucia
AU - Breitenbach, Marisa Dreyer
AU - Fernández, Elmer
AU - Fernández, Jorge
AU - Fernández, Wanda
AU - Franco-Topete, Ramon A.
AU - Gaete, Fancy
AU - Gómez, Jorge
AU - Gonzalez-Ramirez, Leivy P.
AU - Guerrero, Marisol
AU - Gutierrez-Rubio, Susan A.
AU - Jalfin, Beatriz
AU - Lopez-Vazquez, Alejandra
AU - Loria, Dora
AU - Míguez, Silvia
AU - Moran-Mendoza, Andres de J.
AU - Morgan-Villela, Gilberto
AU - Mussetti, Carina
AU - Nagai, Maria Aparecida
AU - Oceguera-Villanueva, Antonio
AU - Reis, Rui M.
AU - Retamales, Javier
AU - Rodriguez, Robinson
N1 - Publisher Copyright:
Copyright © 2022 de Almeida, Cortés, Vilensky, Valenzuela, Cortes-Sanabria, de Souza, Barbeito, Abdelhay, Artagaveytia, Daneri-Navarro, Llera, Müller, Podhajcer, Velazquez, Alcoba, Alonso, Bravo, Camejo, Carraro, Castro, Cataldi, Cayota, Cerda, Colombo, Crocamo, Del Toro-Arreola, Delgadillo-Cristerna, Delgado, Breitenbach, Fernández, Fernández, Fernández, Franco-Topete, Gaete, Gómez, Gonzalez-Ramirez, Guerrero, Gutierrez-Rubio, Jalfin, Lopez-Vazquez, Loria, Míguez, Moran-Mendoza, Morgan-Villela, Mussetti, Nagai, Oceguera-Villanueva, Reis, Retamales, Rodriguez, Rosales, Salas-Gonzalez, Segovia, Sendoya, Silva-Garcia, Viña, Zagame, Jones, Szklo and United States-Latin American Cancer Research Network (US-LACRN).
PY - 2022/3/8
Y1 - 2022/3/8
N2 - Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes were described, and the 60-month overall cumulative survival probabilities (OS) were estimated. From 2011 to 2013, 1,300 eligible Latin-American women 18 years or older, with a diagnosis of breast cancer in clinical stage II or III, and performance status ≦̸1 were invited to participate in a prospective cohort study. Face-to-face interviews were conducted, and clinical and outcome data, including death, were extracted from medical records. Unadjusted associations were evaluated by Chi-squared and Fisher’s exact tests and the OS by Kaplan–Meier method. Log-rank test was used to determine differences between cumulative probability curves. Multivariable adjustment was carried out by entering potential confounders in the Cox regression model. The OS at 60 months was 83.9%. Multivariable-adjusted death hazard differences were found for women living in Argentina (2.27), Chile (1.95), and Uruguay (2.42) compared with Mexican women, for older (≥60 years) (1.84) compared with younger (≤40 years) women, for basal-like subtype (5.8), luminal B (2.43), and HER2-enriched (2.52) compared with luminal A subtype, and for tumor clinical stages IIB (1.91), IIIA (3.54), and IIIB (3.94) compared with stage IIA women. OS was associated with country of residence, PAM50 intrinsic subtype, age, and tumor stage at diagnosis. While the latter is known to be influenced by access to care, including cancer screening, timely diagnosis and treatment, including access to more effective treatment protocols, it may also influence epigenetic changes that, potentially, impact molecular subtypes. Data derived from heretofore understudied populations with unique geographic ancestry and sociocultural experiences are critical to furthering our understanding of this complexity.
AB - Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes were described, and the 60-month overall cumulative survival probabilities (OS) were estimated. From 2011 to 2013, 1,300 eligible Latin-American women 18 years or older, with a diagnosis of breast cancer in clinical stage II or III, and performance status ≦̸1 were invited to participate in a prospective cohort study. Face-to-face interviews were conducted, and clinical and outcome data, including death, were extracted from medical records. Unadjusted associations were evaluated by Chi-squared and Fisher’s exact tests and the OS by Kaplan–Meier method. Log-rank test was used to determine differences between cumulative probability curves. Multivariable adjustment was carried out by entering potential confounders in the Cox regression model. The OS at 60 months was 83.9%. Multivariable-adjusted death hazard differences were found for women living in Argentina (2.27), Chile (1.95), and Uruguay (2.42) compared with Mexican women, for older (≥60 years) (1.84) compared with younger (≤40 years) women, for basal-like subtype (5.8), luminal B (2.43), and HER2-enriched (2.52) compared with luminal A subtype, and for tumor clinical stages IIB (1.91), IIIA (3.54), and IIIB (3.94) compared with stage IIA women. OS was associated with country of residence, PAM50 intrinsic subtype, age, and tumor stage at diagnosis. While the latter is known to be influenced by access to care, including cancer screening, timely diagnosis and treatment, including access to more effective treatment protocols, it may also influence epigenetic changes that, potentially, impact molecular subtypes. Data derived from heretofore understudied populations with unique geographic ancestry and sociocultural experiences are critical to furthering our understanding of this complexity.
KW - Latin America
KW - breast cancer
KW - global excellence
KW - molecular subtypes
KW - oncology
KW - prognosis
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85133949975&partnerID=8YFLogxK
U2 - 10.3389/fonc.2022.845527
DO - 10.3389/fonc.2022.845527
M3 - Artículo
C2 - 35530311
AN - SCOPUS:85133949975
SN - 2234-943X
VL - 12
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 845527
ER -